Literature DB >> 25521007

Landmark clinical trials influencing surgical management of non-invasive and invasive breast cancer.

Thomas B Julian1, Charis A Venditti, Shivani Duggal.   

Abstract

The surgical management of breast cancer has changed considerably since the use of the Halstedian radical mastectomy early in the 20th century. Over the last 50 years, several landmark clinical trials from the USA and Europe have resulted in a paradigm shift in the management of breast cancer toward less radical forms of surgery with the combined use of multi-modality treatments including systemic chemotherapy, endocrine therapy, and radiotherapy. Advances in such research have established a new worldwide standard of care for breast cancer surgical management and treatment, which has become more patient centric and which places a higher emphasis on cosmesis and improved patient quality of life. In this chapter, we review the landmark clinical trials that have influenced surgical management for non-invasive and invasive breast cancer and that serve to guide current clinical practices to date.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  breast cancer; clinical trials; research

Mesh:

Year:  2014        PMID: 25521007     DOI: 10.1111/tbj.12363

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  3 in total

1.  The 21-gene recurrence score in special histologic subtypes of breast cancer with favorable prognosis.

Authors:  Gulisa Turashvili; Edi Brogi; Monica Morrow; Clifford Hudis; Maura Dickler; Larry Norton; Hannah Y Wen
Journal:  Breast Cancer Res Treat       Date:  2017-06-03       Impact factor: 4.872

2.  Delayed initiation of radiation therapy is associated with inferior outcomes for breast cancer patients with hormone receptor-negative tumors after breast-conserving surgery.

Authors:  Xiaoyan Ma; Jie Chen; Ding Ma; Yizhou Jiang; Zhebin Liu; Sheng Chen; Ying Zhang; Yizhou Shen; Xiaoli Yu; Zhaozhi Yang; Shuang Li; Miao Mo; Yongxiang Qian; Guangyu Liu; Jiong Wu; Zhiming Shao; Keda Yu; Genhong Di
Journal:  Gland Surg       Date:  2021-09

3.  Strategies to Improve Recruitment to a De-escalation Trial: A Mixed-Methods Study of the OPTIMA Prelim Trial in Early Breast Cancer.

Authors:  C Conefrey; J L Donovan; R C Stein; S Paramasivan; A Marshall; J Bartlett; D Cameron; A Campbell; J Dunn; H Earl; P Hall; V Harmer; L Hughes-Davies; I Macpherson; A Makris; A Morgan; S Pinder; C Poole; D Rea; L Rooshenas
Journal:  Clin Oncol (R Coll Radiol)       Date:  2020-02-20       Impact factor: 4.126

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.